Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

Aug 27, 2025

BUY
$5.37 - $10.46 $59,134 - $115,185
11,012 New
11,012 $107,000
Q1 2025

May 15, 2025

SELL
$5.37 - $10.46 $43,276 - $84,297
-8,059 Reduced 42.26%
11,012 $107,000
Q4 2024

Feb 14, 2025

BUY
$4.52 - $10.98 $86,200 - $209,399
19,071 New
19,071 $103,000

Others Institutions Holding NVCT

About Nuvectis Pharma, Inc.


  • Ticker NVCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 14,642,500
  • Market Cap $88.1M
  • Description
  • Nuvectis Pharma, Inc., a biopharmaceutical company, focuses on the development of precision medicines for the treatment of serious unmet medical needs in oncology. It develops NXP800, a novel heat shock factor 1 pathway inhibitor for the treatment of various cancers; and NXP900, a small molecule drug candidate to inhibit the Proto-oncogene c-Src...
More about NVCT
Track This Portfolio

Track Squarepoint Ops LLC Portfolio

Follow Squarepoint Ops LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.